These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15046259)

  • 21. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
    Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
    Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
    Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics.
    Yang Y; Ganusov VV
    Front Immunol; 2018; 9():140. PubMed ID: 29472921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
    Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection on the human immunodeficiency virus type 1 proteome following primary infection.
    Liu Y; McNevin J; Cao J; Zhao H; Genowati I; Wong K; McLaughlin S; McSweyn MD; Diem K; Stevens CE; Maenza J; He H; Nickle DC; Shriner D; Holte SE; Collier AC; Corey L; McElrath MJ; Mullins JI
    J Virol; 2006 Oct; 80(19):9519-29. PubMed ID: 16973556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI
    Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of sequence evolution at epitopes for host antibodies and cytotoxic T-lymphocytes in human immunodeficiency virus type 1.
    Piontkivska H; Hughes AL
    Virus Res; 2006 Mar; 116(1-2):98-105. PubMed ID: 16214253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection.
    Liu Y; Mullins JI; Mittler JE
    Virology; 2006 Mar; 347(1):140-6. PubMed ID: 16387340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.
    Friedrich TC; McDermott AB; Reynolds MR; Piaskowski S; Fuenger S; De Souza IP; Rudersdorf R; Cullen C; Yant LJ; Vojnov L; Stephany J; Martin S; O'Connor DH; Wilson N; Watkins DI
    J Virol; 2004 Sep; 78(18):10064-73. PubMed ID: 15331739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.
    Montefiori DC; Altfeld M; Lee PK; Bilska M; Zhou J; Johnston MN; Gao F; Walker BD; Rosenberg ES
    J Immunol; 2003 Apr; 170(7):3906-14. PubMed ID: 12646660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escape of human immunodeficiency virus from immune control.
    McMichael AJ; Phillips RE
    Annu Rev Immunol; 1997; 15():271-96. PubMed ID: 9143689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.
    Wolinsky SM; Korber BT; Neumann AU; Daniels M; Kunstman KJ; Whetsell AJ; Furtado MR; Cao Y; Ho DD; Safrit JT
    Science; 1996 Apr; 272(5261):537-42. PubMed ID: 8614801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.
    O'Connor D; Friedrich T; Hughes A; Allen TM; Watkins D
    Immunol Rev; 2001 Oct; 183():115-26. PubMed ID: 11782252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.